CD33 and neoplasm: The MDSC populations (30) were marked as eMDSC (Lineage–CD11b+CD33+), amounting at 0.06%, and as PMN-MDSC (CD45+CD15+CD14–CD11b+), amounting at 0.11% of the total tumor cell suspension in GCT (Figure 1H).